Abstract
Pharmacokinetics describes the path of a drug in the body; its major constituents are
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abernethy DR, Schwartz JB, Plachetka JR et al (1987) Comparison in young and elderly patients of pharmacodynamics and disposition of labetolol in systemic hypertension. Am J Cardiol 60:697–702
Bertilsson L, Dahl ML, Ingelman-Sundberg M, Johansson I, Sjoqvist F (1995) Interindividual and interethnic differences in polymorphic drug oxidation – implication for drug therapy with focus on psychoactive drugs. In: G Pacifici, GN Fracchia (Hrsg) Advances in drug metabolism in man. EUR 15439 EN, EC, DGXII-E-4. Office for Publication of the European Commission, Luxembourg, pp 85–136
Burkhardt H, Wehling M, Gladisch R (2007) Prevention of drug side effects in the elderly. Z Gerontol Geriatr 40:241–254, in German
Campion EW, Avorn J, Reder VA, Olins NJ (1987) Overmedication of the low-weight elderly. Arch Intern Med 147:945–947
Chen S, Chou WH, Blouin RA et al (1996) The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: screening costs and influence on clinical outcomes in psychiatry. Clin Pharmacol Ther 60:522–534
Clive DM, Stoff JS (1984) Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 310:563–572
Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41
Delafuente JC (2003) Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 48:133–143
Feuring M, Wehling M, Falkenstein E (2000) Impact of genetic factors and diseases on drug action. Internist 41:332–337, in German
Goeptar AR, Scheerens H, Vermeulen NP (1995) Oxygen and xenobiotic reductase activities of cytochrome P450. Crit Rev Toxicol 25:25–65
Klotz U (2009) Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 41:67–76
Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130:461–470
Lewis DF, Watson E, Lake BG (1998) Evolution of the cytochrome P450 superfamily: sequence alignments and pharmacogenetics. Mutat Res 410:245–270
Lindeman RD (1993) Assessment of renal function in the old: special considerations. Clin Lab Med 13:269–277
Podrazik PM, Schwartz JB (1999) Cardiovascular pharmacology of aging. Cardiol Clin 17:17–34
Rowe JW, Andres R, Tobin JD et al (1976) The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 31:155–163
Wormhoudt LW, Commandeur JN, Vermeulen NP (1999) Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity. Crit Rev Toxicol 29:59–124
Zeeh J, Platt D (2002) The aging liver: structural and functional changes and their consequences for drug treatment in old age. Gerontology 48:121–127
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Wien
About this chapter
Cite this chapter
Wehling, M. (2013). Age-Associated General Pharmacological Aspects. In: Wehling, M. (eds) Drug Therapy for the Elderly. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0912-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-7091-0912-0_3
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-0911-3
Online ISBN: 978-3-7091-0912-0
eBook Packages: MedicineMedicine (R0)